Trials / Conditions / Molecular Targeted Therapy
Molecular Targeted Therapy
6 registered clinical trials studyying Molecular Targeted Therapy — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Benmelstobart-Anlotinib-Chemo for Neoadjuvant Oral Cancer NCT06848439 | Jiangsu Cancer Institute & Hospital | Phase 2 |
| Not Yet Recruiting | Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitor NCT06523049 | Hao Zeng | Phase 2 |
| Active Not Recruiting | Camrelizumab Combined With Apatinib Mesylate for Perioperative Treatment of Resectable Hepatocellular Carcinom NCT04521153 | Shanghai Zhongshan Hospital | Phase 2 / Phase 3 |
| Completed | Lenvatinib Combined With Gefitinib in the Treatment of Lenvatinib-resistant Hepatocellular Carcinoma NCT04642547 | RenJi Hospital | N/A |
| Unknown | Apatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment Failur NCT04586088 | Sun Yat-sen University | Phase 2 |
| Unknown | Observational Studies of the Application of Bevacizumab in HER2-negative Breast Cancer Neoadjuvant Chemotherap NCT01652560 | LiNanlin,Ph.D, Chief Physician,Clinical Professor | — |